Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Tucci

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|September 17, 2015
Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphomaGiacomo Pata, Enrico Damiani, Michele Bartoli, et al.
Annals of Hematology|February 19, 2024
2-[<sup>18</sup>]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcomeDomenico Albano, Anna CalabrĂ², Anna Talin, et al.
Hematological Oncology|October 10, 2018
Prognostic role of baseline <sup>18</sup> F-FDG PET/CT parameters in MALT lymphomaDomenico Albano, Giovanni Bosio, Luca Camoni, et al.
Annals of Nuclear Medicine|April 1, 2019
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphomaDomenico Albano, Giovanni Bosio, Nicola Bianchetti, et al.
Leukemia & Lymphoma|February 25, 2014
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphomaPier Luigi Zinzani, Massimo Federico, Stefano Oliva, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancerFederica Merlin, Tiziana Prochilo, Basem Kildani, et al.
Leukemia & Lymphoma|July 15, 2006
Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatmentsChiara Cattaneo, Pierangelo Spedini, Salvatore Casari, et al.
Vaccines|May 26, 2026
Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational StudyRosa Daffini, Francesco Zecchini, Giulia Venneri, et al.
Journal of Microbiological Methods|July 13, 2013
Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infectionsGiovanna Pulcrano, Dora Vita Iula, Antonio Vollaro, et al.
Haematologica|March 8, 2005
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosisAlessandra Tucci, Maddalena Motta, Marco Ungari, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|September 17, 2015
Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphomaGiacomo Pata, Enrico Damiani, Michele Bartoli, et al.
Annals of Hematology|February 19, 2024
2-[<sup>18</sup>]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcomeDomenico Albano, Anna CalabrĂ², Anna Talin, et al.
Hematological Oncology|October 10, 2018
Prognostic role of baseline <sup>18</sup> F-FDG PET/CT parameters in MALT lymphomaDomenico Albano, Giovanni Bosio, Luca Camoni, et al.
Annals of Nuclear Medicine|April 1, 2019
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphomaDomenico Albano, Giovanni Bosio, Nicola Bianchetti, et al.
Leukemia & Lymphoma|February 25, 2014
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphomaPier Luigi Zinzani, Massimo Federico, Stefano Oliva, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancerFederica Merlin, Tiziana Prochilo, Basem Kildani, et al.
Leukemia & Lymphoma|July 15, 2006
Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatmentsChiara Cattaneo, Pierangelo Spedini, Salvatore Casari, et al.
Vaccines|May 26, 2026
Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational StudyRosa Daffini, Francesco Zecchini, Giulia Venneri, et al.
Journal of Microbiological Methods|July 13, 2013
Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infectionsGiovanna Pulcrano, Dora Vita Iula, Antonio Vollaro, et al.
Haematologica|March 8, 2005
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosisAlessandra Tucci, Maddalena Motta, Marco Ungari, et al.
Pageof 16